Loading…
Utility of immunohistochemistry in breast cancer practice
Immunohistochemistry (IHC) has been used to search for specific protein-products, to observe the unique characteristics of breast cancer, to differentiate breast cancer from cancers of other sites origin, to obtain information regarding genetic alterations, to investigate prognostic factors, and to...
Saved in:
Published in: | Breast cancer (Tokyo, Japan) Japan), 2004-11, Vol.11 (4), p.334-338 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c253t-764bd6dd7b843dcefa1ea72e279f846fa0165142edc847446ba43552855fcb603 |
---|---|
cites | cdi_FETCH-LOGICAL-c253t-764bd6dd7b843dcefa1ea72e279f846fa0165142edc847446ba43552855fcb603 |
container_end_page | 338 |
container_issue | 4 |
container_start_page | 334 |
container_title | Breast cancer (Tokyo, Japan) |
container_volume | 11 |
creator | Umemura, Shinobu Osamura, R Yoshiyuki |
description | Immunohistochemistry (IHC) has been used to search for specific protein-products, to observe the unique characteristics of breast cancer, to differentiate breast cancer from cancers of other sites origin, to obtain information regarding genetic alterations, to investigate prognostic factors, and to provide predictive factors for efficient treatments. Technical developments make it possible to utilize IHC as a convenient diagnostic tool, and to use it in advanced protocols in combination with other histochemical techniques as well. In this review article, the development of IHC, IHC for differential diagnosis and IHC for providing information about hormone receptors and HER2 in breast cancer practice will be introduced. Standardization and quality control are critical issues to utilize IHC adequately in breast cancer practice. |
doi_str_mv | 10.1007/BF02968039 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67189500</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67189500</sourcerecordid><originalsourceid>FETCH-LOGICAL-c253t-764bd6dd7b843dcefa1ea72e279f846fa0165142edc847446ba43552855fcb603</originalsourceid><addsrcrecordid>eNpFkM1Kw0AYRQdRbK1ufADJyoUQ_eZ_stRiVSi4seswmXxDI_mpM5NF396UFrq6d3G4XA4h9xSeKYB-eVsBK5QBXlyQOTUGcsE4v5w6F5Aro8yM3MT4CyC4BnVNZlQqEIXRc1JsUtM2aZ8NPmu6buyHbRPT4LbYTRn2WdNnVUAbU-Zs7zBku2Bdahzekitv24h3p1yQzer9Z_mZr78_vpav69wxyVOulahqVde6MoLXDr2laDVDpgtvhPIWqJJUMKydEVoIVVnBpWRGSu8qBXxBHo-7uzD8jRhTOT1z2La2x2GMpdLUFBIO4NMRdGGIMaAvd6HpbNiXFMqDqPIsaoIfTqtj1WF9Rk9m-D82HmKG</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67189500</pqid></control><display><type>article</type><title>Utility of immunohistochemistry in breast cancer practice</title><source>Springer Nature</source><creator>Umemura, Shinobu ; Osamura, R Yoshiyuki</creator><creatorcontrib>Umemura, Shinobu ; Osamura, R Yoshiyuki</creatorcontrib><description>Immunohistochemistry (IHC) has been used to search for specific protein-products, to observe the unique characteristics of breast cancer, to differentiate breast cancer from cancers of other sites origin, to obtain information regarding genetic alterations, to investigate prognostic factors, and to provide predictive factors for efficient treatments. Technical developments make it possible to utilize IHC as a convenient diagnostic tool, and to use it in advanced protocols in combination with other histochemical techniques as well. In this review article, the development of IHC, IHC for differential diagnosis and IHC for providing information about hormone receptors and HER2 in breast cancer practice will be introduced. Standardization and quality control are critical issues to utilize IHC adequately in breast cancer practice.</description><identifier>ISSN: 1340-6868</identifier><identifier>EISSN: 1880-4233</identifier><identifier>DOI: 10.1007/BF02968039</identifier><identifier>PMID: 15604987</identifier><language>eng</language><publisher>Japan</publisher><subject>Breast Neoplasms - diagnosis ; Breast Neoplasms - metabolism ; Female ; Humans ; Immunohistochemistry - methods ; Immunohistochemistry - standards ; Neoplasms, Hormone-Dependent - diagnosis ; Neoplasms, Hormone-Dependent - metabolism ; Predictive Value of Tests ; Receptor, ErbB-2 - metabolism</subject><ispartof>Breast cancer (Tokyo, Japan), 2004-11, Vol.11 (4), p.334-338</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c253t-764bd6dd7b843dcefa1ea72e279f846fa0165142edc847446ba43552855fcb603</citedby><cites>FETCH-LOGICAL-c253t-764bd6dd7b843dcefa1ea72e279f846fa0165142edc847446ba43552855fcb603</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15604987$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Umemura, Shinobu</creatorcontrib><creatorcontrib>Osamura, R Yoshiyuki</creatorcontrib><title>Utility of immunohistochemistry in breast cancer practice</title><title>Breast cancer (Tokyo, Japan)</title><addtitle>Breast Cancer</addtitle><description>Immunohistochemistry (IHC) has been used to search for specific protein-products, to observe the unique characteristics of breast cancer, to differentiate breast cancer from cancers of other sites origin, to obtain information regarding genetic alterations, to investigate prognostic factors, and to provide predictive factors for efficient treatments. Technical developments make it possible to utilize IHC as a convenient diagnostic tool, and to use it in advanced protocols in combination with other histochemical techniques as well. In this review article, the development of IHC, IHC for differential diagnosis and IHC for providing information about hormone receptors and HER2 in breast cancer practice will be introduced. Standardization and quality control are critical issues to utilize IHC adequately in breast cancer practice.</description><subject>Breast Neoplasms - diagnosis</subject><subject>Breast Neoplasms - metabolism</subject><subject>Female</subject><subject>Humans</subject><subject>Immunohistochemistry - methods</subject><subject>Immunohistochemistry - standards</subject><subject>Neoplasms, Hormone-Dependent - diagnosis</subject><subject>Neoplasms, Hormone-Dependent - metabolism</subject><subject>Predictive Value of Tests</subject><subject>Receptor, ErbB-2 - metabolism</subject><issn>1340-6868</issn><issn>1880-4233</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNpFkM1Kw0AYRQdRbK1ufADJyoUQ_eZ_stRiVSi4seswmXxDI_mpM5NF396UFrq6d3G4XA4h9xSeKYB-eVsBK5QBXlyQOTUGcsE4v5w6F5Aro8yM3MT4CyC4BnVNZlQqEIXRc1JsUtM2aZ8NPmu6buyHbRPT4LbYTRn2WdNnVUAbU-Zs7zBku2Bdahzekitv24h3p1yQzer9Z_mZr78_vpav69wxyVOulahqVde6MoLXDr2laDVDpgtvhPIWqJJUMKydEVoIVVnBpWRGSu8qBXxBHo-7uzD8jRhTOT1z2La2x2GMpdLUFBIO4NMRdGGIMaAvd6HpbNiXFMqDqPIsaoIfTqtj1WF9Rk9m-D82HmKG</recordid><startdate>20041124</startdate><enddate>20041124</enddate><creator>Umemura, Shinobu</creator><creator>Osamura, R Yoshiyuki</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20041124</creationdate><title>Utility of immunohistochemistry in breast cancer practice</title><author>Umemura, Shinobu ; Osamura, R Yoshiyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c253t-764bd6dd7b843dcefa1ea72e279f846fa0165142edc847446ba43552855fcb603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Breast Neoplasms - diagnosis</topic><topic>Breast Neoplasms - metabolism</topic><topic>Female</topic><topic>Humans</topic><topic>Immunohistochemistry - methods</topic><topic>Immunohistochemistry - standards</topic><topic>Neoplasms, Hormone-Dependent - diagnosis</topic><topic>Neoplasms, Hormone-Dependent - metabolism</topic><topic>Predictive Value of Tests</topic><topic>Receptor, ErbB-2 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Umemura, Shinobu</creatorcontrib><creatorcontrib>Osamura, R Yoshiyuki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Breast cancer (Tokyo, Japan)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Umemura, Shinobu</au><au>Osamura, R Yoshiyuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Utility of immunohistochemistry in breast cancer practice</atitle><jtitle>Breast cancer (Tokyo, Japan)</jtitle><addtitle>Breast Cancer</addtitle><date>2004-11-24</date><risdate>2004</risdate><volume>11</volume><issue>4</issue><spage>334</spage><epage>338</epage><pages>334-338</pages><issn>1340-6868</issn><eissn>1880-4233</eissn><abstract>Immunohistochemistry (IHC) has been used to search for specific protein-products, to observe the unique characteristics of breast cancer, to differentiate breast cancer from cancers of other sites origin, to obtain information regarding genetic alterations, to investigate prognostic factors, and to provide predictive factors for efficient treatments. Technical developments make it possible to utilize IHC as a convenient diagnostic tool, and to use it in advanced protocols in combination with other histochemical techniques as well. In this review article, the development of IHC, IHC for differential diagnosis and IHC for providing information about hormone receptors and HER2 in breast cancer practice will be introduced. Standardization and quality control are critical issues to utilize IHC adequately in breast cancer practice.</abstract><cop>Japan</cop><pmid>15604987</pmid><doi>10.1007/BF02968039</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1340-6868 |
ispartof | Breast cancer (Tokyo, Japan), 2004-11, Vol.11 (4), p.334-338 |
issn | 1340-6868 1880-4233 |
language | eng |
recordid | cdi_proquest_miscellaneous_67189500 |
source | Springer Nature |
subjects | Breast Neoplasms - diagnosis Breast Neoplasms - metabolism Female Humans Immunohistochemistry - methods Immunohistochemistry - standards Neoplasms, Hormone-Dependent - diagnosis Neoplasms, Hormone-Dependent - metabolism Predictive Value of Tests Receptor, ErbB-2 - metabolism |
title | Utility of immunohistochemistry in breast cancer practice |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T21%3A24%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Utility%20of%20immunohistochemistry%20in%20breast%20cancer%20practice&rft.jtitle=Breast%20cancer%20(Tokyo,%20Japan)&rft.au=Umemura,%20Shinobu&rft.date=2004-11-24&rft.volume=11&rft.issue=4&rft.spage=334&rft.epage=338&rft.pages=334-338&rft.issn=1340-6868&rft.eissn=1880-4233&rft_id=info:doi/10.1007/BF02968039&rft_dat=%3Cproquest_cross%3E67189500%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c253t-764bd6dd7b843dcefa1ea72e279f846fa0165142edc847446ba43552855fcb603%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67189500&rft_id=info:pmid/15604987&rfr_iscdi=true |